Agios Pharms Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for AGIOS PHARMS INC, and what generic alternatives to AGIOS PHARMS INC drugs are available?
AGIOS PHARMS INC has one approved drug.
There are seven US patents protecting AGIOS PHARMS INC drugs.
There are one hundred and twenty-five patent family members on AGIOS PHARMS INC drugs in forty-four countries and eight supplementary protection certificates in seven countries.
Summary for Agios Pharms Inc
| International Patents: | 125 |
| US Patents: | 7 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Agios Pharms Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Agios Pharms Inc | PYRUKYND | mitapivat sulfate | TABLET;ORAL | 216196-002 | Feb 17, 2022 | RX | Yes | No | 9,193,701 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Agios Pharms Inc | PYRUKYND | mitapivat sulfate | TABLET;ORAL | 216196-001 | Feb 17, 2022 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Agios Pharms Inc | PYRUKYND | mitapivat sulfate | TABLET;ORAL | 216196-002 | Feb 17, 2022 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Agios Pharms Inc | PYRUKYND | mitapivat sulfate | TABLET;ORAL | 216196-002 | Feb 17, 2022 | RX | Yes | No | 11,234,976 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Agios Pharms Inc | PYRUKYND | mitapivat sulfate | TABLET;ORAL | 216196-001 | Feb 17, 2022 | RX | Yes | No | 9,682,080 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Agios Pharms Inc | PYRUKYND | mitapivat sulfate | TABLET;ORAL | 216196-001 | Feb 17, 2022 | RX | Yes | No | 10,632,114 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Agios Pharms Inc | PYRUKYND | mitapivat sulfate | TABLET;ORAL | 216196-002 | Feb 17, 2022 | RX | Yes | No | 9,980,961 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Agios Pharms Inc Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Australia | 2018373122 | ⤷ Try a Trial |
| Taiwan | I649313 | ⤷ Try a Trial |
| Taiwan | I598337 | ⤷ Try a Trial |
| South Korea | 102024027 | ⤷ Try a Trial |
| Taiwan | I472522 | ⤷ Try a Trial |
| Canada | 2834602 | ⤷ Try a Trial |
| Taiwan | I691493 | ⤷ Try a Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Agios Pharms Inc Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2448582 | 122023000025 | Germany | ⤷ Try a Trial | PRODUCT NAME: MITAPIVAT ODER EIN PHARMAZEUTISCH AKZEPTABLES SALZ DAVON, INSBESONDERE MITAPIVATSULFAT; REGISTRATION NO/DATE: EU/1/22/1662 20221109 |
| 2448582 | CA 2023 00014 | Denmark | ⤷ Try a Trial | PRODUCT NAME: MITAPIVAT ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF, ISAER MITAPIVATSULFAT; REG. NO/DATE: EU/1/22/1662 20221110 |
| 2448582 | LUC00306 | Luxembourg | ⤷ Try a Trial | PRODUCT NAME: MITAPIVAT OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, IN PARTICULAR MITAPIVAT SULFATE; AUTHORISATION NUMBER AND DATE: EU/1/22/1662 20221110 |
| 2448582 | 2023C/517 | Belgium | ⤷ Try a Trial | PRODUCT NAME: MITAPIVAT OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI, EN PARTICULIER LE SULFATE DE MITAPIVAT; AUTHORISATION NUMBER AND DATE: EU/1/22/1662 20221110 |
| 2448582 | CR 2023 00014 | Denmark | ⤷ Try a Trial | PRODUCT NAME: MITAPIVAT ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF, ISAER MITAPIVATSULFAT; REG. NO/DATE: EU/1/22/1662 20221110 |
| 2448582 | PA2023513 | Lithuania | ⤷ Try a Trial | PRODUCT NAME: MITAPIVATAS ARBA JO FARMACINIU POZIURIU PRIIMTINA DRUSKA, YPAC MITAPIVATO SULFATAS; REGISTRATION NO/DATE: EU/1/22/1662 20221109 |
| 2448582 | 301230 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: MITAPIVAT, DAN WEL EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN, IN HET BIJZONDER MITAPIVATSULFAAT; REGISTRATION NO/DATE: EU/1/22/1662 20221110 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
